Adverse drug effects observed with vildagliptin versus pioglitazone or rosiglitazone in the treatment of patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Adverse drug effects observed with vildagliptin versus pioglitazone or rosiglitazone in the treatment of patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials

Published:2017-10-23 Issue:1 Volume:18 Page:
ISSN:2050-6511
Container-title:BMC Pharmacology and Toxicology
language:en
Short-container-title:BMC Pharmacol Toxicol

Author:

Bundhun Pravesh Kumar,Janoo Girish,Teeluck Abhishek Rishikesh,Huang Feng^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

http://link.springer.com/content/pdf/10.1186/s40360-017-0175-0.pdf

Reference15 articles.

1. Ristic S, Byiers S, Foley J, Holmes D. Improved glycaemic control with dipeptidyl peptidase-4 inhibition in patients with type 2 diabetes: vildagliptin(LAF237) dose response. Diabetes Obes Metab. 2005 Nov;7(6):692–8.

2. Ahrén B, Landin-Olsson M, Jansson PA, Svensson M, Holmes D, Schweizer A. Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagon levels intype 2 diabetes. J Clin Endocrinol Metab. 2004 May;89(5):2078–84.

3. K H, Mortensen LS. Bodyweight changes associated with antihyperglycaemic agents in type 2 diabetes mellitus. Drug Saf. 2007;30(12):1127–42.

4. Lago RM, Singh PP, Nesto RW. Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials. Lancet. 2007 Sep 29;370(9593):1129–36.

5. Higgins JPT AD. Cochrane handbook for systematic reviews of interventions: Wiley; 2008.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Comprehensive Physiologically Based Pharmacokinetic Model for Predicting Vildagliptin Pharmacokinetics: Insights into Dosing in Renal Impairment;Pharmaceuticals;2024-07-10

2. Anti-Diabetic Potential of Sargassum horneri and Ulva australis Extracts In Vitro and In Vivo;Current Issues in Molecular Biology;2023-09-13

3. Antihyperglycemic efficacy and safety of AKROPOL, a Persian medicine poly-herbal extract mixture, in the treatment of type 2 diabetic patients: a randomized, double-blind and placebo-controlled clinical trial;The Payam-e-Marefat-Kabul Education University;2023-05-01

4. A Scoping Review of the Use of Pioglitazone in the Treatment of Temporo-Mandibular Joint Arthritis;International Journal of Environmental Research and Public Health;2022-12-09

5. An obesogenic feedforward loop involving PPARγ, acyl-CoA binding protein and GABAA receptor;Cell Death & Disease;2022-04-18